Genpact LTD (G) stock
GNYSEServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 21/3024% below fair value
$43.13−0.47 (-1.08%)
Close on Nov 12, 2026Market cap $7.25BP/E 12.6Yield 1.58%
Genpact EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Genpact's EPS for the twelve months ending Sep 30, 2026 was $3.43, up 10.6% year over year. For fiscal 2025 it was $3.13, up 9.8% from the year before. Over ten years it grew 11.1% a year on average. The highest annual figure on record is $3.41 in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.13 | +9.8% |
| FY2024 | Dec 31, 2024 | $2.85 | -16.4% |
| FY2023 | Dec 31, 2023 | $3.41 | +81.4% |
| FY2022 | Dec 31, 2022 | $1.88 | -1.6% |
| FY2021 | Dec 31, 2021 | $1.91 | +21.7% |
| FY2020 | Dec 31, 2020 | $1.57 | +0.6% |
| FY2019 | Dec 31, 2019 | $1.56 | +7.6% |
| FY2018 | Dec 31, 2018 | $1.45 | +8.2% |
| FY2017 | Dec 31, 2017 | $1.34 | +4.7% |
| FY2016 | Dec 31, 2016 | $1.28 | +17.4% |
| FY2015 | Dec 31, 2015 | $1.09 | +28.2% |
| FY2014 | Dec 31, 2014 | $0.85 | -12.4% |
| FY2013 | Dec 31, 2013 | $0.97 | +24.4% |
| FY2012 | Dec 31, 2012 | $0.78 | -3.7% |
| FY2011 | Dec 31, 2011 | $0.81 | +28.6% |
| FY2010 | Dec 31, 2010 | $0.63 | +8.6% |
| FY2009 | Dec 31, 2009 | $0.58 | +1.8% |
| FY2008 | Dec 31, 2008 | $0.57 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.89 | +7.2% |
| Q2 FY2026 | Jun 30, 2026 | $0.86 | +14.7% |
| Q1 FY2026 | Mar 31, 2026 | $0.86 | +17.8% |
| Q4 FY2025 | Dec 31, 2025 | $0.82 | +3.8% |
| Q3 FY2025 | Sep 30, 2025 | $0.83 | +12.2% |
| Q2 FY2025 | Jun 30, 2025 | $0.75 | +11.9% |
| Q1 FY2025 | Mar 31, 2025 | $0.73 | +14.1% |
| Q4 FY2024 | Dec 31, 2024 | $0.79 | -50.3% |
| Q3 FY2024 | Sep 30, 2024 | $0.74 | +15.6% |
| Q2 FY2024 | Jun 30, 2024 | $0.67 | +6.3% |
| Q1 FY2024 | Mar 31, 2024 | $0.64 | +12.3% |
| Q4 FY2023 | Dec 31, 2023 | $1.59 | +231.3% |
| Q3 FY2023 | Sep 30, 2023 | $0.64 | +25.5% |
| Q2 FY2023 | Jun 30, 2023 | $0.63 | +65.8% |
| Q1 FY2023 | Mar 31, 2023 | $0.57 | +11.8% |
| Q4 FY2022 | Dec 31, 2022 | $0.48 | +26.3% |
| Q3 FY2022 | Sep 30, 2022 | $0.51 | -3.8% |
| Q2 FY2022 | Jun 30, 2022 | $0.38 | -28.3% |
| Q1 FY2022 | Mar 31, 2022 | $0.51 | +8.5% |
| Q4 FY2021 | Dec 31, 2021 | $0.38 | 0.0% |
| Q3 FY2021 | Sep 30, 2021 | $0.53 | +23.3% |
| Q2 FY2021 | Jun 30, 2021 | $0.53 | +65.6% |
| Q1 FY2021 | Mar 31, 2021 | $0.47 | +6.8% |
| Q4 FY2020 | Dec 31, 2020 | $0.38 | -9.5% |
| Q3 FY2020 | Sep 30, 2020 | $0.43 | -4.4% |
| Q2 FY2020 | Jun 30, 2020 | $0.32 | -15.8% |
| Q1 FY2020 | Mar 31, 2020 | $0.44 | +41.9% |
| Q4 FY2019 | Dec 31, 2019 | $0.42 | +2.4% |
| Q3 FY2019 | Sep 30, 2019 | $0.45 | +18.4% |
| Q2 FY2019 | Jun 30, 2019 | $0.38 | +15.2% |
| Q1 FY2019 | Mar 31, 2019 | $0.31 | -6.1% |
| Q4 FY2018 | Dec 31, 2018 | $0.41 | +20.6% |
| Q3 FY2018 | Sep 30, 2018 | $0.38 | 0.0% |
| Q2 FY2018 | Jun 30, 2018 | $0.33 | -8.3% |
| Q1 FY2018 | Mar 31, 2018 | $0.33 | +26.9% |
| Q4 FY2017 | Dec 31, 2017 | $0.34 | -10.5% |
| Q3 FY2017 | Sep 30, 2017 | $0.38 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.36 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.26 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.38 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?